People and Places
Medilink UK appoints new CEO Medilink UK, the largest representative body for the Health Technology sector in the UK, has appointed Kevin Kiely as its CEO.
K
evin was co-founder of the Medilink model over twenty five years ago, which for the first time brought together in a formal regional association, the health technology and related life sciences industry, the NHS and universities, to drive innovation across the sector.
During this time, he has developed a deep understanding and connectivity with the sector throughout the UK and overseas, which plays a key role in the health and wealth of the nation. Kevin is uniquely placed to work with national agencies to ensure that the needs of the health technology and related life sciences sector are fully considered in all future developments and that opportunities, post Brexit, are realised. Bill Cruise, Medilink UK Chairman, said:
Our industry has always been on the front line when it comes to responding to the changing needs of healthcare delivery but never before has this been more visible than in the current Covid-19 crisis - whether this be in developing antigen / antibody tests, precision engineered components for ventilators, the supply of PPE or accelerating the production of urgently needed medical equipment. It has never been more important for Medilink UK to have national representation and I feel privileged to have been asked to undertake this role.”
“The strength of Medilink UK continues to be the in-depth relationships that its constituent Medilink organisations have in regions across the UK. However, the sector is facing unprecedented challenges, not least with the current Coronavirus pandemic, and it has become clear that Medilink UK needs to play a more proactive national role if challenges are to be overcome and future opportunities realised. I am therefore delighted to announce the appointment of Medilink UK’s first national CEO, Kevin Kiely.” Kevin Kiely said: “Having been involved in the development of regional Medilink organisations across the UK for over 25 years, and seeing the Medilink UK infrastructure grow to a point where it is now the largest representative body for the health technology industry, I understand many of the challenges facing our members, not only now with the unprecedented impact of the coronavirus pandemic but with the ongoing challenges of innovation (particularly regulation) and internationalisation.
Medilink UK is a national representative organisation for the health technology and related life sciences sector. It is a unique partnership between industry, the NHS, universities and UK Government organisations, with a strong track record in increasing the viability of manufacturers, service providers, designers, OEMs and suppliers of healthcare technology. Medilink UK plays an important role in driving the health and wealth of the nation by addressing the day-to-day issues that face the health technology and related life sciences sector and helping drive the development of products and services from concept through to commercialisation, as well as nurturing collaboration between academics, clinicians and industry. Medilink UK brings together regional Medilink organisations into a vibrant national partnership and is the largest representative healthcare technology body in the UK, with over 1600 member organisations
www.medilinkuk.com
For daily lifescience news visit www.lifescienceindustrynews.com 35
